Scheduling Optimization of a Compact End-to-End Pharmaceutical Manufacturing Line: Design and Experimental Evaluation

Research output: Contribution to journalArticlepeer-review

Abstract

In today’s competitive landscape, the demand for scheduling optimization to enhance processes and industrial plants is rapidly increasing. To address this need, we introduce a scheduling optimization approach for a compact continuous pharmaceutical manufacturing line by developing a mixed integer linear programming (MILP) model that incorporates all necessary constraints and bounds. The MILP employs a continuous time representation and an extension to a multi-product manufacturing line to improve the capabilities of current equipment and the model itself is shown. To reinforce the ideas and exemplify the overall concept, we present simulation results, demonstrating the optimal scheduling plans for various scenarios. In a case study, we applied the MILP to a manufacturing line and successfully integrated the optimal scheduling plan into the plant. Our results show that the time constraints, expected mass flows, and mass hold-ups align with those of the optimal scheduling plan, confirming that fully automated and integrated operations are feasible.
Original languageEnglish
Article number72
Number of pages21
JournalJournal of Pharmaceutical Innovation
Volume20
Issue number2
DOIs
Publication statusPublished - Apr 2025

Keywords

  • Scheduling optimization
  • Integration into an operational manufacturing line
  • · Fully optimized and automated operation
  • Continuous pharmaceutical manufacturing
  • Fully optimized and automated operation

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Scheduling Optimization of a Compact End-to-End Pharmaceutical Manufacturing Line: Design and Experimental Evaluation'. Together they form a unique fingerprint.

Cite this